Filing Details
- Accession Number:
- 0001209191-14-015066
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-27 21:00:19
- Reporting Period:
- 2014-02-25
- Filing Date:
- 2014-02-27
- Accepted Time:
- 2014-02-27 21:00:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1087432 | Intermune Inc | ITMN | Pharmaceutical Preparations (2834) | 943296648 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1206199 | G Daniel Welch | 3280 Bayshore Boulevard Brisbane CA 94005 | Chairman, Ceo And President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-02-25 | 41,087 | $25.55 | 178,521 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-02-25 | 41,087 | $32.63 | 137,434 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Common Stock (Right to Buy) | Disposition | 2014-02-25 | 41,087 | $0.00 | 41,087 | $25.55 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2014-05-15 | No | 4 | M | Direct |
Footnotes
- The transaction was made pursuant to the terms of the 10b5-1 plan in effect at the time of the transaction.
- Represents the weighted average sale price for the entire number of shares sold. The sale prices range from $32.41 to $33.31 per share. Full information on the numbers of shares sold at each sale price is available upon request.
- Fully Exercisable.
Billionaire Hedge Funds
